CD274 and neoplasm: While Nrf2 activators, such as sulforaphane, reduce PD-L1 in specific contexts, hyperactivation in squamous malignancies is correlated with immunosuppressive tumor-associated macrophage (TAM) polarization and poor survival outcomes [134,136].